Crisnatol
(Synonyms: BWA770U) 目录号 : GC68904Crisnatol (BWA770U) 是一种口服有效的抗癌剂和芳甲基氨基丙二醇类 DNA 插入器。Crisnatol 对人类乳腺癌细胞显示出体外细胞毒性,但对正常的人类皮肤成纤维细胞无效。
Cas No.:96389-68-3
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Crisnatol (BWA770U) is an orally active and anticancer agent, and a member of the arylmetlaminopropanediol class of DNA intercalators. Crisnatol shows in vitro cytotoxicity against human breast Inhibited cell viability at 48 hr.
Crisnatol (25 mg/kg; p.o.; single dose) 显示出口服活性,并通过放射自显影显示大鼠粪便提取物的稳定代谢物谱[2]。
[1]. Adams DJ. In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator. Cancer Res. 1989 Dec 1;49(23):6615-20.
[2]. Patel DK, et al. Metabolism of a novel antitumor agent, crisnatol, by a human hepatoma cell line, Hep G2, and hepatic microsomes. Characterization of metabolites. Biochem Pharmacol. 1991 Jul 5;42(2):337-46.
[3]. Patel DK, et al. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat. Drug Metab Dispos. 1991 Mar-Apr;19(2):491-7.
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.8949 mL | 14.4747 mL | 28.9494 mL |
5 mM | 0.579 mL | 2.8949 mL | 5.7899 mL |
10 mM | 0.2895 mL | 1.4475 mL | 2.8949 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。